Literature DB >> 7796837

Seronegative chronic relapsing neuroborreliosis.

C Lawrence1, R B Lipton, F D Lowy, P K Coyle.   

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796837     DOI: 10.1159/000117104

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

1.  Value of Patient Population Selection and Lyme Borreliosis Tests.

Authors:  Alexis Lacout; Pierre Yves Marcy; Marie Mas; Christian Perronne; Michel Franck
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

Review 2.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 3.  Physician preferences in the diagnosis and treatment of Lyme disease in the United States.

Authors:  M H Ziska; S T Donta; F C Demarest
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

5.  Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

Authors:  Marika Nordberg; Pia Forsberg; Dag Nyman; Barbro H Skogman; Clara Nyberg; Jan Ernerudh; Ingvar Eliasson; Christina Ekerfelt
Journal:  Cells       Date:  2012-06-08       Impact factor: 6.600

6.  Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms.

Authors:  Leena Meriläinen; Anni Herranen; Armin Schwarzbach; Leona Gilbert
Journal:  Microbiology       Date:  2015-01-06       Impact factor: 2.777

7.  The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.

Authors:  Marcus Davidsson
Journal:  Healthcare (Basel)       Date:  2018-02-13

8.  "Repurposing" Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years' Experience in One Medical Practice.

Authors:  Jiachen Gao; Zhaodi Gong; Dawn Montesano; Erica Glazer; Kenneth Liegner
Journal:  Antibiotics (Basel)       Date:  2020-12-04

9.  Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.

Authors:  Samuel Shor; Christine Green; Beatrice Szantyr; Steven Phillips; Kenneth Liegner; Joseph Jr Burrascano; Robert Bransfield; Elizabeth L Maloney
Journal:  Antibiotics (Basel)       Date:  2019-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.